PubMed

Inhibition of HIV derived lentiviral production by TAR RNA binding domain of TAT protein.

Mi MY, Zhang J, He Y.

Retrovirology. 2005 Nov 17;2:71.PMID: 16293193 [PubMed - indexed for MEDLINE]Related articlesFree article

Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS.

Lisziewicz J, Sun D, Smythe J, Lusso P, Lori F, Louie A, Markham P, Rossi J, Reitz M, Gallo RC.

Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8000-4.PMID: 8367455 [PubMed - indexed for MEDLINE]Related articlesFree article

Inhibition of HIV-1 replication by anti-trans-activation responsive polyamide nucleotide analog.

Kaushik N, Basu A, Pandey VN.

Antiviral Res. 2002 Oct;56(1):13-27.PMID: 12323396 [PubMed - indexed for MEDLINE]Related articles

Targeting of HIV-1 Tat traffic and function by transduction-competent single chain antibodies.

Theisen DM, Pongratz C, Wiegmann K, Rivero F, Krut O, Krönke M.

Vaccine. 2006 Apr 12;24(16):3127-36. Epub 2006 Feb 9.PMID: 16497417 [PubMed - indexed for MEDLINE]Related articles

Inhibition of Tat-mediated transactivation of HIV-1 LTR transcription by polyamide nucleic acid targeted to TAR hairpin element.

Mayhood T, Kaushik N, Pandey PK, Kashanchi F, Deng L, Pandey VN.

Biochemistry. 2000 Sep 26;39(38):11532-9.PMID: 10995220 [PubMed - indexed for MEDLINE]Related articles

Inhibition of HIV-1 Tat-dependent trans activation by steric block chimeric 2'-O-methyl/LNA oligoribonucleotides.

Arzumanov A, Walsh AP, Rajwanshi VK, Kumar R, Wengel J, Gait MJ.

Biochemistry. 2001 Dec 4;40(48):14645-54.PMID: 11724578 [PubMed - indexed for MEDLINE]Related articles

An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replication.

Hamy F, Felder ER, Heizmann G, Lazdins J, Aboul-ela F, Varani G, Karn J, Klimkait T.

Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):3548-53.PMID: 9108013 [PubMed - indexed for MEDLINE]Related articlesFree article

Structure of TAR RNA complexed with a Tat-TAR interaction nanomolar inhibitor that was identified by computational screening.

Du Z, Lind KE, James TL.

Chem Biol. 2002 Jun;9(6):707-12.PMID: 12079782 [PubMed - indexed for MEDLINE]Related articles

Structure-based computational database screening, in vitro assay, and NMR assessment of compounds that target TAR RNA.

Lind KE, Du Z, Fujinaga K, Peterlin BM, James TL.

Chem Biol. 2002 Feb;9(2):185-93.PMID: 11880033 [PubMed - indexed for MEDLINE]Related articles

Alpha,alpha-trehalose derivatives bearing guanidino groups as inhibitors to HIV-1 Tat-TAR RNA interaction in human cells.

Wang M, Xu Z, Tu P, Yu X, Xiao S, Yang M.

Bioorg Med Chem Lett. 2004 May 17;14(10):2585-8.PMID: 15109657 [PubMed - indexed for MEDLINE]Related articles

Tricyclo-DNA containing oligonucleotides as steric block inhibitors of human immunodeficiency virus type 1 tat-dependent trans-activation and HIV-1 infectivity.

Ivanova G, Reigadas S, Ittig D, Arzumanov A, Andreola ML, Leumann C, Toulmé JJ, Gait MJ.

Oligonucleotides. 2007 Spring;17(1):54-65.PMID: 17461763 [PubMed - indexed for MEDLINE]Related articles

Inhibition of HIV-LTR gene expression by oligonucleotides targeted to the TAR element.

Vickers T, Baker BF, Cook PD, Zounes M, Buckheit RW Jr, Germany J, Ecker DJ.

Nucleic Acids Res. 1991 Jun 25;19(12):3359-68.PMID: 2062653 [PubMed - indexed for MEDLINE]Related articlesFree article

Nuclear Factor 90(NF90) targeted to TAR RNA inhibits transcriptional activation of HIV-1.

Agbottah ET, Traviss C, McArdle J, Karki S, St Laurent GC 3rd, Kumar A.

Retrovirology. 2007 Jun 12;4:41.PMID: 17565699 [PubMed - indexed for MEDLINE]Related articlesFree article

Doxorubicin inhibits Tat-dependent transactivation of HIV type 1 LTR.

Jeyaseelan R, Kurabayashi M, Kedes L.

AIDS Res Hum Retroviruses. 1996 May 1;12(7):569-76.PMID: 8743082 [PubMed - indexed for MEDLINE]Related articles

Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists.

Mhashilkar AM, Biswas DK, LaVecchio J, Pardee AB, Marasco WA.

J Virol. 1997 Sep;71(9):6486-94.PMID: 9261367 [PubMed - indexed for MEDLINE]Related articlesFree article

Discoveries of Tat-TAR interaction inhibitors for HIV-1.

Yang M.

Curr Drug Targets Infect Disord. 2005 Dec;5(4):433-44. Review.PMID: 16535863 [PubMed - indexed for MEDLINE]Related articles

Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication.

Chen H, He J, Fong S, Wilcox G, Wood C.

J Virol. 2000 Mar;74(6):2703-13.PMID: 10684286 [PubMed - indexed for MEDLINE]Related articlesFree article

TAR-independent activation of HIV-1 requires the activation domain but not the RNA-binding domain of Tat.

Taylor JP, Kundu M, Khalili K.

Virology. 1993 Aug;195(2):780-5.PMID: 8337844 [PubMed - indexed for MEDLINE]Related articles

Inhibitors of HIV-1 Tat-mediated transactivation.

Richter SN, Palù G.

Curr Med Chem. 2006;13(11):1305-15. Review.PMID: 16712471 [PubMed - indexed for MEDLINE]Related articles

Interaction of YB-1 with human immunodeficiency virus type 1 Tat and TAR RNA modulates viral promoter activity.

Ansari SA, Safak M, Gallia GL, Sawaya BE, Amini S, Khalili K.

J Gen Virol. 1999 Oct;80 ( Pt 10):2629-38.PMID: 10573156 [PubMed - indexed for MEDLINE]Related articlesFree article